Related Experiment Video

Updated: Apr 11, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.3K

Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation

Takatsugu Ishimoto1,2, Hideo Baba2, Daisuke Izumi2

  • 1Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School Singapore, Singapore, Singapore.

International Journal of Cancer
|June 5, 2015
PubMed

Insights

MicroRNAs (miRNAs) are crucial in gastric cancer (GC) development and progression. Understanding miRNA roles can lead to early diagnostic biomarkers and new therapies for this common cancer.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Tumorigenesis arises from genetic and epigenetic changes in normal cells.
  • MicroRNAs (miRNAs) are key regulators of gene expression.
  • miRNA dysregulation is implicated in various cancers, including gastric cancer (GC).

Purpose of the Study:

  • To review recent findings on miRNA-mediated regulation in gastric cancer.
  • To highlight the role of miRNAs in GC carcinogenesis, progression, and metastasis.
  • To explore the potential of miRNAs as diagnostic biomarkers and therapeutic targets for GC.

Main Methods:

  • Literature review of recent studies on miRNAs in gastric cancer.
  • Analysis of miRNA-mediated gene regulation mechanisms in GC.
  • Synthesis of evidence linking miRNA alterations to GC development and progression.

Main Results:

  • miRNA dysregulation is a significant factor in GC initiation and metastasis.
  • Specific miRNA alterations can serve as early diagnostic markers for GC.
  • miRNAs offer potential for novel therapeutic strategies against GC.

Conclusions:

  • miRNA-mediated regulation is central to gastric cancer pathogenesis.
  • Targeting miRNAs presents a promising avenue for GC diagnostics and therapeutics.
  • Further research into miRNA mechanisms will advance GC treatment.
Keywords:
H. pyloricancer biomarkergastric cancermicroRNAtherapeutic target

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.7K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.4K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K